- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03879213
Acute Berry Intake on Metabolic Control and Cognitive Function (RRB3)
The Effects of Acute Raspberry Intake on the Relationship Between Enhanced Metabolic Control and Cognitive and Psychomotor Function
The objectives of this study are:
- Evaluate the effects of acute dietary raspberry intake on metabolic-associated impairments in cognitive and psychomotor function in overweight/obese adults (55-70y) following a meal challenge
- Evaluate the effects of acute dietary raspberry on measures of vascular function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed study will be conducted in humans according to Good Clinical Practice (GCP) guidelines. All subjects will review and sign an Informed Consent Form approved by the Illinois Institute of Technology's Institutional Review Boards (IRB) prior to screening.
This multi-center clinical trial is a randomized, single-blind, 2-arm, placebo-controlled, within subject cross-over trial, featuring a repeated postprandial sampling paradigm to evaluate the effects of acute dietary red raspberry intake on cognitive function, inflammation, insulin sensitivity / glucose handling and vascular function in overweight/obese older adults after consuming a standardized challenge meal.
A planned sample size of 30 will be enrolled into the study. This study will require one initial screening visit and 3 study visits. This study will take approximately 3-4 weeks per subject to complete.
The initial screening visit will provide subject with their site-specific, IRB-approved informed consent document prior to the start of any study related procedures. Subject eligibility will be determined through anthropometric measurements, vital signs, fasting blood glucose test (finger prick), and completion of a survey relate to general eating, health, mood and exercise habits.
Eligible subjects will follow a limited polyphenolic diet throughout the duration of their participation, although stricter guidelines will be imposed during the 3 days prior to a study visit. Shopping lists and meal plans will be provided to subjects, along with counseling by the investigator's study dietitians, to help subjects adhere to the limited polyphenolic diet. The trial will initiate with a 3-day food diary to assess background (pre-study) dietary intake followed by counseling to follow a diet relatively low in (poly)phenolic rich-beverages/foods, which will be maintained for the duration of the experiment. After an initial 7 day run-in period on the limited polyphenolic diet, subjects will be randomized to 1 of 2 treatment sequences. Treatment codes will be maintained by the principal investigator/study physician. All subjects will receive both treatments, once each on 2 different occasions and separated by at least 1 week. Red raspberries or placebo will be provided with a standardized meal providing 840 kcal. A low-polyphenol snack will be provided to subjects after their final cognitive assessment.
Each visit will last ~ 9.5 hours and subjects will be required to remain at the Clinical Unit for the duration of the visit. Blood samples will be collected at 0 (fasting) and at 0.5 h, 1 h, 2 h, 4 h, 5 h, 6 h and 7.5 h via a catheter placed on the non-dominant arm by a registered nurse. Cognitive function will be measured at 0 (fasting), 2 h, and 6 h. FMD or NIRS will be conducted at the CNRC or the HNRCA, respectively at 0 (fasting), and at 1 h and 5 h.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60616
- Clinical Nutrition Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI between 27 and 35 kg/m2 and/or waist circumference (>35 inches for women, >40 inches for men)
- Aged 55-70 years old
- Able to provide informed consent and comply with study procedures
- Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial.
- Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests.
Exclusion Criteria:
- Current smoker and/or marijuana user, past smokers may be allowed in the study if stopped >2 years
- Have a history or presence of atherosclerotic cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders
- Have recent surgery or injury to head
- Mini-Mental Status Exam score < 24 or Beck Depression Inventory score > 20
- Taking any medications that would interfere with outcomes of the study (i.e., lipid-lowering medications, anti-inflammatory drugs, and supplements, not including multivitamin/mineral or calcium/Vit D supplements),
- Unstable use of any medication/supplement
- Have a history of cancer in the prior 5 years, except for non-melanoma skin cancer
- Addicted to drugs and/or alcohol (>2 drinks/day)
- Have been exposed to any non-registered drug product within last 30 days.
- Working overnight (e.g. 3rd shift of overnight workers)
- Excessive exercisers or trained athletes
- Have allergies/intolerances to berries.
- Vegetarian/vegan or have extreme dietary habits.
- Excessive coffee/tea drinker
- Actively losing weight/ trying to lose weight (unstable body weight fluctuations of > 5 kg in 3 months)
- Donated blood within last 3 months
- Female who is pregnant, planning to be pregnant, breastfeeding
- Current regular consumption of berries which exceeds > 2 servings per day
- The individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound the interpretation of the study results or put the person at undue risk.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active
freeze-dried red raspberry powder (25 g) in active breakfast meal
|
freeze-dried red raspberry powder (12.5 g) in drink+ freeze-dried red raspberry powder (12.5 g) in buttermilk biscuit sandwich
|
Placebo Comparator: Placebo
Placebo breakfast
|
Control drink + buttermilk biscuit sandwich
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Profile of Mood States response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in Profile of Mood States
|
Baseline to 6 hours
|
Changes in Digit Symbol Coding response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in Digit Symbol Coding
|
Baseline to 6 hours
|
Changes in Hopkins Verbal Learning Test response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in Hopkins Verbal Learning Test
|
Baseline to 6 hours
|
Changes in CANTAB- paired-associates-learning response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in CANTAB- paired-associates-learning
|
Baseline to 6 hours
|
Changes in CANTAB- rapid-visual-information-processing response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in CANTAB- rapid-visual-information-processing
|
Baseline to 6 hours
|
Changes in CANTAB- spatial-working-memory response between 2 treatments
Time Frame: Baseline to 6 hours
|
Cognitive assessment tasks will be performed in CANTAB- spatial-working-memory
|
Baseline to 6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Psychomotor function between 2 treatments
Time Frame: Baseline to 6 hours
|
Psychomotor function will be measured with the Grooved Pegboard
|
Baseline to 6 hours
|
Changes in postprandial endothelial function between 2 treatments
Time Frame: Baseline to 5 hours
|
Vascular Assessments will be measured with Flow mediated vasodilation (FMD)
|
Baseline to 5 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB2018-046
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Active breakfast
-
USDA Human Nutrition Research Center on AgingCompletedObesity | Aging | Age-related Cognitive DeclineUnited States
-
Lund UniversityVinnova; Antidiabetic Food Centre AFCCompleted
-
Tel Aviv UniversityUnknown
-
Tel Aviv UniversityHospital de Clinicas CaracasCompleted
-
University of UlmCompleted
-
University of British ColumbiaCompleted
-
Purdue UniversitySuspendedAppetite and General Nutritional DisordersUnited States
-
Westlake UniversitySun Yat-sen UniversityActive, not recruiting
-
Lund UniversityFood for Health Science Centre, Lund UniversityCompleted
-
Wolfson Medical CenterUnknown